SURG-94. Predictors of surgical success and biochemical remission in Cushing disease: A single institution experience

Abstract INTRODUCTION Cushing’s disease (CD), caused by ACTH-secreting pituitary adenomas, typically presents with chronic hypercortisolemia, causing significant morbidity [1]. Emerging evidence suggests success of biochemical remission with surgery is dependent on preoperative diagnostic thresholds in late-night salivary cortisol (LNSC), 24-hour urinary free cortisol (UFC), or 1-mg dexamethasone suppression test (DST) [2]. Bilateral inferior petrosal sinus sampling (BIPSS) is often performed to confirm central ACTH production, with IPS:P >2 at baseline or >3 after stimulation considered diagnostic [3]. CD remains incompletely characterized; discordant clinical and laboratory findings yield variable surgical outcomes. Objective: To validate previously proposed endocrine cutoffs predictive of surgical remission in a separate cohort. METHODS After IRB approval, we retrospectively reviewed all pituitary adenomas presenting with Cushing’s syndrome treated surgically at our institution over 10 years (n=55). We collected preoperative hormone studies, BIPSS and MRI findings, and outcomes. RESULTS Cushing adenomas fell into four categories: MRI(+)/pathology(+) (n=22), MRI(+)/pathology(-) (n=17), MRI(-)/pathology(+) (n=3), and MRI(-)/pathology(-) (n=13). Remission rates varied from 100% in MRI(-)/pathology(+) to 36.4% in MRI(-)/pathology(-) (p=0.002). MRI(+)/pathology(+) had higher remission odds than MRI(-)/pathology(-) (OR 4.96, 95%CI 1.06-23.16, p=0.019). There were no significant differences in LNSC/DST/UFC levels. ACTH levels were higher in MRI(+)/pathology(+) (99.4 pg/mL) than MRI(+)/pathology(-) (41.6 pg/mL, p=0.017) and MRI(-)/pathology(-) (40.3 pg/mL, p=0.014). Using logistic regression analysis, only ACTH levels predicted remission (OR 1.03, 95%CI 1.01-1.05, p=0.008). Basal IPS:P in MRI(+)/pathology(+) was significantly higher than in MRI(+)/pathology(-) (9.4 vs. 3.5, p=0.022). Furthermore, basal IPS:P >2 was a significant predictor of remission (OR 3.65, p=0.019) but maximum IPS:P >3 was not (p=0.145). CONCLUSIONS Only preoperative ACTH levels and basal IPS:P >2 predicted surgical remission. These findings support refining preoperative endocrine evaluation and patient selection in Cushing’s disease.

Authors

Institutions

Publication Details

Journal
Neuro-Oncology
Published
2025-11-01
DOI
https://doi.org/10.1093/neuonc/noaf201.1646
Primary Topic
Pituitary Gland Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

SURG-94. Predictors of surgical success and biochemical remission in Cushing disease: A single institution experience

Sarah M. Smith, Edward C. Kuan, Joshua Kurtz, Ahmed Mohyeldin et al.
Neuro-Oncology
Pituitary Gland Disorders and Treatments
article

SURG-94. Predictors of surgical success and biochemical remission in Cushing disease: A single institution experience

Sarah M. Smith, Edward C. Kuan, Joshua Kurtz, Ahmed Mohyeldin, Frank P. K. Hsu, Alexander Himstead, Andrew Kwon
article en

Abstract

Abstract INTRODUCTION Cushing’s disease (CD), caused by ACTH-secreting pituitary adenomas, typically presents with chronic hypercortisolemia, causing significant morbidity [1]. Emerging evidence suggests success of biochemical remission with surgery is dependent on preoperative diagnostic thresholds in late-night salivary cortisol (LNSC), 24-hour urinary free cortisol (UFC), or 1-mg dexamethasone suppression test (DST) [2]. Bilateral inferior petrosal sinus sampling (BIPSS) is often performed to confirm central ACTH production, with IPS:P >2 at baseline or >3 after stimulation considered diagnostic [3]. CD remains incompletely characterized; discordant clinical and laboratory findings yield variable surgical outcomes. Objective: To validate previously proposed endocrine cutoffs predictive of surgical remission in a separate cohort. METHODS After IRB approval, we retrospectively reviewed all pituitary adenomas presenting with Cushing’s syndrome treated surgically at our institution over 10 years (n=55). We collected preoperative hormone studies, BIPSS and MRI findings, and outcomes. RESULTS Cushing adenomas fell into four categories: MRI(+)/pathology(+) (n=22), MRI(+)/pathology(-) (n=17), MRI(-)/pathology(+) (n=3), and MRI(-)/pathology(-) (n=13). Remission rates varied from 100% in MRI(-)/pathology(+) to 36.4% in MRI(-)/pathology(-) (p=0.002). MRI(+)/pathology(+) had higher remission odds than MRI(-)/pathology(-) (OR 4.96, 95%CI 1.06-23.16, p=0.019). There were no significant differences in LNSC/DST/UFC levels. ACTH levels were higher in MRI(+)/pathology(+) (99.4 pg/mL) than MRI(+)/pathology(-) (41.6 pg/mL, p=0.017) and MRI(-)/pathology(-) (40.3 pg/mL, p=0.014). Using logistic regression analysis, only ACTH levels predicted remission (OR 1.03, 95%CI 1.01-1.05, p=0.008). Basal IPS:P in MRI(+)/pathology(+) was significantly higher than in MRI(+)/pathology(-) (9.4 vs. 3.5, p=0.022). Furthermore, basal IPS:P >2 was a significant predictor of remission (OR 3.65, p=0.019) but maximum IPS:P >3 was not (p=0.145). CONCLUSIONS Only preoperative ACTH levels and basal IPS:P >2 predicted surgical remission. These findings support refining preoperative endocrine evaluation and patient selection in Cushing’s disease.

Neuro-OncologyVol. 27(Supplement_5)
University of California, Irvine (US), University of California, Irvine Medical Center (US)
Openalex Percentile: Top 54%
Pituitary Gland Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.